Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
5.70
+0.29 (5.36%)
At close: Aug 13, 2025, 4:00 PM
5.71
+0.01 (0.18%)
After-hours: Aug 13, 2025, 7:59 PM EDT
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of $2.48 billion as of August 13, 2025. Its market cap has increased by 10.63% in one year.
Market Cap
2.48B
Enterprise Value
2.04B
1-Year Change
10.63%
Ranking
Category
Stock Price
$5.70
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from $5.08B to $2.48B, a decrease of -51.19%. That is a compound annual growth rate of -15.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 2.35B | -11.80% |
| Dec 31, 2024 | 2.67B | 24.83% |
| Dec 29, 2023 | 2.14B | 46.15% |
| Dec 30, 2022 | 1.46B | -49.51% |
| Dec 31, 2021 | 2.89B | -42.96% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 585.16B |
| Johnson & Johnson | 418.50B |
| AbbVie | 349.14B |
| UnitedHealth Group | 233.24B |
| Abbott Laboratories | 229.48B |
| AstraZeneca | 227.85B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |